A clinical comparison of two different surgical techniques in the treatment of acute Achilles tendon ruptures: Limited-open approach vs. percutaneous approach.

Akut aşil tendon rüptürlerinin tedavisinde iki farklı tekniğin klinik karşılaştırılması: Sınırlı açık yaklaşıma karşı perkütan yaklaşım.

Journal

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES
ISSN: 1307-7945
Titre abrégé: Ulus Travma Acil Cerrahi Derg
Pays: Turkey
ID NLM: 101274231

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 14 8 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Surgical treatment is the commonly preferred method for treating acute Achilles tendon ruptures (AATRs) due to advantages such as less re-rupture rates, better functional results, and an early return to physical activities. The main aim of our study is to compare two common minimally invasive surgical methods, the limited open and the percutaneous approaches, regarding clinical outcomes. A total of 53 patients (19 females and 34 males) who were treated with limited open (Group 1: 30 patients) and percutaneous (Group 2: 23 patients) approaches for AATRs were retrospectively evaluated between March 2019 and May 2020 in a level 1 trauma center. The evaluation included complications (soft tissue and skin problems, re-rupture, and sural nerve injury rates), the operation time, the duration of return to daily activities, The Achilles Tendon Total Rupture Score (ATRS), and the American Ortho-pedic Foot and Ankle Society (AOFAS) scores of the patients at the first and 6th months of follow-up. Patients' activity levels were compared with the Tegner Activity Scale (TAS). The mean age of all patients in this cohort was 45.1±14.1. The mean postoperative follow-up period for group 1 was 36.9±8.81 weeks, whereas, for group 2, it was 35.4±8.73 weeks (P=0.24). The mean age (P=0.47), gender distribution (P=0.41), and body mass index (P=0.29) were similar for both groups. The mean operation time (group 1: 47.1±5.4 vs. group 2: 44.4±6.1, P=0.06) and the duration of return to daily activities (group 1: 49.2±7.4 vs. group 2: 48.5±9.7, P=0.38) were also similar. There was no statistical difference between groups regarding functional results at first (ATRS: group 1: 79.9±3.2 vs. group 2: 79.5±3.9, [P=0.35], and AOFAS: group 1: 80.9±3.1 vs. group 2: 82.1±3.2, [P=0.10]) and 6th months (ATRS: group 1: 85.0±3.8 vs. group 2: 83.7±4.4, [P=0.13], and AO-FAS: group 1: 86.6±3.6 vs. group 2: 86.7±4.2, [P=0.46]). There were no statistically significant differences between groups regarding preoperative and last follow-up TAS scores (P= 0.94 and P=0.46, respectively). We observed no postoperative complications in group 1. There were three complications (13.1%) in group 2. One patient (4.4%) had a re-rupture, and two patients (8.7%) had sural nerve injuries. Although both groups had similar functional results, the limited open approach yielded better clinical outcomes according to the complication results than the percutaneous approach.

Sections du résumé

BACKGROUND BACKGROUND
Surgical treatment is the commonly preferred method for treating acute Achilles tendon ruptures (AATRs) due to advantages such as less re-rupture rates, better functional results, and an early return to physical activities. The main aim of our study is to compare two common minimally invasive surgical methods, the limited open and the percutaneous approaches, regarding clinical outcomes.
METHODS METHODS
A total of 53 patients (19 females and 34 males) who were treated with limited open (Group 1: 30 patients) and percutaneous (Group 2: 23 patients) approaches for AATRs were retrospectively evaluated between March 2019 and May 2020 in a level 1 trauma center. The evaluation included complications (soft tissue and skin problems, re-rupture, and sural nerve injury rates), the operation time, the duration of return to daily activities, The Achilles Tendon Total Rupture Score (ATRS), and the American Ortho-pedic Foot and Ankle Society (AOFAS) scores of the patients at the first and 6th months of follow-up. Patients' activity levels were compared with the Tegner Activity Scale (TAS).
RESULTS RESULTS
The mean age of all patients in this cohort was 45.1±14.1. The mean postoperative follow-up period for group 1 was 36.9±8.81 weeks, whereas, for group 2, it was 35.4±8.73 weeks (P=0.24). The mean age (P=0.47), gender distribution (P=0.41), and body mass index (P=0.29) were similar for both groups. The mean operation time (group 1: 47.1±5.4 vs. group 2: 44.4±6.1, P=0.06) and the duration of return to daily activities (group 1: 49.2±7.4 vs. group 2: 48.5±9.7, P=0.38) were also similar. There was no statistical difference between groups regarding functional results at first (ATRS: group 1: 79.9±3.2 vs. group 2: 79.5±3.9, [P=0.35], and AOFAS: group 1: 80.9±3.1 vs. group 2: 82.1±3.2, [P=0.10]) and 6th months (ATRS: group 1: 85.0±3.8 vs. group 2: 83.7±4.4, [P=0.13], and AO-FAS: group 1: 86.6±3.6 vs. group 2: 86.7±4.2, [P=0.46]). There were no statistically significant differences between groups regarding preoperative and last follow-up TAS scores (P= 0.94 and P=0.46, respectively). We observed no postoperative complications in group 1. There were three complications (13.1%) in group 2. One patient (4.4%) had a re-rupture, and two patients (8.7%) had sural nerve injuries.
CONCLUSION CONCLUSIONS
Although both groups had similar functional results, the limited open approach yielded better clinical outcomes according to the complication results than the percutaneous approach.

Identifiants

pubmed: 37563893
doi: 10.14744/tjtes.2023.90839
pmc: PMC10560806
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

935-943

Références

J Bone Joint Surg Am. 2018 Nov 21;100(22):1969-1981
pubmed: 30480601
Foot Ankle Surg. 2020 Feb;26(2):209-217
pubmed: 30853390
Bone Joint Res. 2018 Nov 03;7(10):561-569
pubmed: 30464836
Am J Sports Med. 2014 Oct;42(10):2419-23
pubmed: 25056989
J Am Acad Orthop Surg. 2017 Jan;25(1):23-31
pubmed: 27898509
Orthop Clin North Am. 2020 Jul;51(3):391-402
pubmed: 32498958
Foot Ankle Int. 2004 Apr;25(4):215-8
pubmed: 15132928
Arch Orthop Trauma Surg. 2021 May;141(5):751-760
pubmed: 32367375
Foot Ankle Int. 2015 Nov;36(11):1279-86
pubmed: 26055259
BMC Musculoskelet Disord. 2021 Oct 30;22(1):914
pubmed: 34717595
Arch Orthop Trauma Surg. 2021 Mar;141(3):383-401
pubmed: 32266518
J Foot Ankle Surg. 2018 Jan - Feb;57(1):179-183
pubmed: 29113706
Arthrosc Tech. 2021 Jan 16;10(2):e451-e455
pubmed: 33680778
Clin Biomech (Bristol, Avon). 2008 Nov;23(9):1158-64
pubmed: 18639961
Foot Ankle Int. 2009 May;30(5):391-7
pubmed: 19439137
Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):784-92
pubmed: 16456878
Knee Surg Sports Traumatol Arthrosc. 2008 Feb;16(2):204-9
pubmed: 18066530
Foot Ankle Surg. 2021 Jun;27(4):427-431
pubmed: 32553425
Clin Orthop Relat Res. 1977 Oct;(128):247-55
pubmed: 340096
Ulus Travma Acil Cerrahi Derg. 2014 Sep;20(5):311-8
pubmed: 25541841
Int J Surg. 2017 Apr;40:178-186
pubmed: 28288878
Injury. 2014 Nov;45(11):1782-90
pubmed: 25059505
Arch Orthop Trauma Surg. 2020 Nov;140(11):1775-1782
pubmed: 32712822

Auteurs

İzzet Özay Subaşı (İÖ)

Department of Orthopedics and Traumatology, Erzincan University, Faculty of Medicine, Erzincan-Türkiye.

Şahin Çepni (Ş)

Department of Orthopedics and Traumatology, Bilkent City Hospital, Ankara-Türkiye.

Oğuzhan Tanoğlu (O)

Department of Orthopedics and Traumatology, Buca Seyfi Demirsoy Training and Research Hospital, İzmir-Türkiye.

Enejd Veizi (E)

Department of Orthopedics and Traumatology, Bilkent City Hospital, Ankara-Türkiye.

Hilmi Alkan (H)

Department of Orthopedics and Traumatology, Bilkent City Hospital, Ankara-Türkiye.

Furkan Yapici (F)

Department of Orthopedics and Traumatology, Erzincan University, Faculty of Medicine, Erzincan-Türkiye.

Ahmet Firat (A)

Department of Orthopedics and Traumatology, Bilkent City Hospital, Ankara-Türkiye.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH